Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMD14 | O00487 | 1/20 | 0.37 |
| ▸ | COPS5 | Q92905 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | TDP2 | O95551 | 1/20 | 0.35 |
| ▸ | NSD2 | O96028 | 1/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL10002546 | 0.97 | PSMD14 (0.35) | PSMD14COPS5CYP1A2TSHRCYP2A6 | |
| SCHEMBL28105930 | 0.87 | ACHE (0.33) | PSMD14COPS5TSHRACHE | |
| SCHEMBL6129794 | 0.83 | KEAP1 (0.38) | CYP1A2TSHRTDP2NSD2HSP90AA1 | |
| SCHEMBL37955 | 0.79 | TSHR (0.45) | CYP1A2TSHRCYP2A6TDP2NSD2 | |
| SCHEMBL5494672 | 0.79 | TSHR (0.45) | CYP1A2TSHRCYP2A6TDP2NSD2 | |
| SCHEMBL29352563 | 0.79 | TSHR (0.45) | CYP1A2TSHRCYP2A6TDP2NSD2 | |
| SCHEMBL29367536 | 0.79 | PSMD14 (0.35) | PSMD14COPS5CYP1A2POLB | |
| SCHEMBL551215 | 0.79 | PSMD14 (0.35) | PSMD14COPS5CYP1A2TSHRCYP2A6 | |
| SCHEMBL330523 | 0.79 | PSMD14 (0.35) | PSMD14COPS5CYP1A2POLB | |
| SCHEMBL5181689 | 0.75 | TSHR (0.43) | CYP1A2TSHRCYP2A6TDP2NSD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101103288-A | Method for producing plastic optical device having refractive index distribution | FUJI PHOTO FILM CO LTD (JP) | 2008-01-09 | — | — | CN | claimed |
| CN-1859893-A | Photoinitiators with triarylsulfonium ions and arylsulfinate ions | 3M INNOVATIVE PROPERTIES CO (US) | 2006-11-08 | — | — | CN | claimed |
| CN-119278221-A | Curable fluoropolymer compositions comprising catalyst and bisphthalonitrile-containing compound and articles cured therefrom | 3M创新有限公司 | 2025-01-07 | — | — | CN | disclosed |
| CN-118459372-A | Preparation method of photoacid generator sulfonate for ARF photoresist | 常州朗芯新材料科技有限公司 | 2024-08-09 | — | — | CN | disclosed |
| EP-3848399-B1 | TRANSITION METAL COMPOUND AND METHOD FOR PRODUCING OLEFIN POLYMER | IDEMITSU KOSAN CO (JP) | 2024-07-10 | — | — | EP | disclosed |
| EP-4395521-A1 | CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE COMPRISING THE CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS COMPRISING THE LIGHT-EMITTING DEVICE | Samsung Display Co., Ltd. (KR) | 2024-07-03 | — | — | EP | disclosed |
| EP-4365180-A1 | RARE EARTH COMPLEX | Tosoh Corporation (JP) | 2024-05-08 | — | — | EP | disclosed |
| CN-117616032-A | Rare earth complex | 东曹株式会社 | 2024-02-27 | — | — | CN | disclosed |
| CN-117467307-A | curable composition | 东京应化工业株式会社 | 2024-01-30 | — | — | CN | disclosed |
| US-11795188-B2 | Transition metal compound and method for producing olefin polymer | IDEMITSU KOSAN CO., LTD. (JP) | 2023-10-24 | — | — | US | disclosed |
| US-20230235202-A1 | PLASTICIZER FOR RESINS | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-07-27 | — | — | US | disclosed |
| EP-0469022-B1 | PROCESS FOR PRESULPHURIZING A CATALYSER FOR TREATING HYDROCARBONS | EUROPEENNE DE RETRAITEMENT DE CATALYSEURS (en abrégé EURECAT) (FR) | 1993-04-21 | — | — | EP | disclosed |
| US-5175167-A | Fungicides | BASF AKTIENGESELLSCHAFT (DE) | 1992-12-29 | — | — | US | disclosed |
| EP-0469022-A1 | PROCESS FOR PRESULPHURIZING A CATALYSER FOR TREATING HYDROCARBONS. | EURECAT EUROP RETRAIT CATALYS (FR) | 1992-02-05 | — | — | EP | disclosed |
| EP-0466567-A1 | Selective hydrogenation of diolefins in steam cracker naphtha on metal supported catalysts on which an organic sulfur compound had been incorporated before loading into the reactor | Institut Français du Pétrole (FR) | 1992-01-15 | — | — | EP | disclosed |
| EP-0441207-A2 | Heteroaryl alkenes, process for their preparation, intermediates and their use | BASF Aktiengesellschaft (DE) | 1991-08-14 | — | — | EP | disclosed |
| EP-0409680-A1 | Pretreatment process of a refining catalyst | EURECAT EUROPEENNE DE RETRAITEMENT DE CATALYSEURS (FR) | 1991-01-23 | — | — | EP | disclosed |
| WO-1990012647-A1 | PROCESS FOR PRESULPHURIZING A CATALYSER FOR TREATING HYDROCARBONS | EUROPEENNE DE RETRAITEMENT DE CATALYSEURS EURECAT (FR) | 1990-11-01 | — | — | WO | disclosed |
| EP-0377743-A1 | STEROID COMPOUNDS | KURARAY CO., LTD. (JP) | 1990-07-18 | — | — | EP | disclosed |
| US-4119638-A | Thio-ester of 1 (p-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid | G. D. SEARLE & CO. (US) | 1978-10-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795188-B2 | Transition metal compound and method for producing olefin polymer | H1-0, C9, C5 | PSMD14 3047/4885COPS5 1401/4885CYP1A2 1949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.